Production (Stage)
TELA Bio, Inc.
TELA
$2.07
$0.062.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -98.98% | 28.56% | 5.34% | -16.77% | 52.93% |
| Total Depreciation and Amortization | 14.10% | 65.22% | 20.64% | 16.36% | 8.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.97% | 37.94% | 3.67% | 0.32% | -414.45% |
| Change in Net Operating Assets | 81.72% | -866.97% | -137.34% | 104.01% | -97.63% |
| Cash from Operations | 32.39% | 31.85% | -28.92% | 5.03% | -24.28% |
| Capital Expenditure | 89.47% | -28.78% | 8.96% | -90.45% | -164.35% |
| Sale of Property, Plant, and Equipment | -- | 45,233.33% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -96.60% | -- | -- | -- | -- |
| Cash from Investing | -97.06% | 1.55% | 8.96% | 142.68% | 4,183.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -84.11% | 164,973.08% | 53.95% | -99.99% | 772.73% |
| Repurchase of Common Stock | 46.04% | -175.00% | -280.00% | -1,000.00% | -17.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -307.14% | 194,936.36% | 38.03% | -100.01% | 123.83% |
| Foreign Exchange rate Adjustments | -391.30% | 1,200.00% | -469.70% | -107.79% | 58.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.62% | 415.57% | -30.17% | -130.30% | 19.41% |